Literature DB >> 3170809

Scleromyxedema: therapeutic response to isotretinoin in three patients.

C P Milam1, L E Cohen, N A Fenske, N S Ling.   

Abstract

Scleromyxedema is a rare type of papular mucinosis that exhibits a generalized lichenoid pattern. A wide variety of clinical manifestations can occur in patients with this disease. Cutaneous involvement is characteristic, but neurologic, cardiovascular, renal, neoplastic, and other systemic manifestations have been described. A monoclonal gammopathy may be present. Many treatment modalities have been used in the past for scleromyxedema. None, however, have shown consistently favorable results. This report concerns the cases of three patients with scleromyxedema who were treated with isotretinoin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3170809     DOI: 10.1016/s0190-9622(88)70199-1

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

Review 1.  Updated Physician's Guide to the Off-label Uses of Oral Isotretinoin.

Authors:  Steven Brandon Nickle; Nathan Peterson; Michael Peterson
Journal:  J Clin Aesthet Dermatol       Date:  2014-04

2.  [Scleromyxedema. A chronic progressive systemic disease].

Authors:  A Kreuter; M Stücker; A G A Kolios; P Altmeyer; K Möllenhoff
Journal:  Z Rheumatol       Date:  2012-08       Impact factor: 1.372

3.  Scleromyxedema: a case report and review of the literature.

Authors:  Mohamed Allam; Mohamed Ghozzi
Journal:  Case Rep Dermatol       Date:  2013-06-11

4.  Scleromyxedema: a rare disorder and its treatment difficulties.

Authors:  Sandra Koleta Koronowska; Agnieszka Osmola-Mańkowska; Oliwia Jakubowicz; Ryszard Zaba
Journal:  Postepy Dermatol Alergol       Date:  2013-04-12       Impact factor: 1.837

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.